Patents by Inventor Marc Vidal
Marc Vidal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10788537Abstract: There is described a dissociating module for monitoring an object and managing electric input into and output from the object, the object being a battery or a load. The dissociating module is for use with at least one other dissociating module. The dissociating module comprises: measuring devices for taking measurements of the object; a microcontroller operatively connected to the measuring devices for receiving the measurements of the objects, and for operative connection to a microcontroller of the at least one other dissociating module for receiving information therefrom; and switches, operatively connected to the microcontroller. The microcontroller, based on at least one of the measurements of the object received and the information received from the at least one other dissociating module, controls opening and closing of the switches for controlling electrical current in the dissociating module.Type: GrantFiled: August 3, 2016Date of Patent: September 29, 2020Assignee: ID3D Technologies inc.Inventor: Marc Vidal
-
Publication number: 20190100534Abstract: Cephem and penem compounds having a styrylmethylene moiety at the 3-position in the cephem or penem ring to which a positively charged leaving group is bonded and wherein the leaving group contains a vicinal diol or is bonded to a unsubstituted or substituted catechol. The leaving group can be a positively charge nitrogen leaving group. Cephems include cephalosporins, cephamycins, carbacephems, and oxacephems. Penems include penems, carbapenems and oxapenems. Preferred cephems are cephalosporins. Preferred penems are carbapenems. Compounds exhibit antibiotic activity against Gram-negative bacteria and/or Gram-positive bacteria. Compounds exhibit antibiotic activity against bacteria which exhibit multi-drug resistance. Compounds of the invention exhibit antibiotic activity against bacterial strains which produce extended spectrum beta-lactamases (ESBL), which produce AmpC beta-lactamases or which produce a carbapenemase.Type: ApplicationFiled: October 4, 2018Publication date: April 4, 2019Inventors: Larry D. SUTTON, Robert ZAMBONI, Patrick BUREAU, Avid HASSANPOUR, Laura MAMANI LAPARRA, Marc VIDAL, Simon WOO, Nancy ZHOU, Richard M. KEENAN
-
Publication number: 20180231614Abstract: There is described a dissociating module for monitoring an object and managing electric input into and output from the object, the object being a battery or a load. The dissociating module is for use with at least one other dissociating module. The dissociating module comprises: measuring devices for taking measurements of the object; a microcontroller operatively connected to the measuring devices for receiving the measurements of the objects, and for operative connection to a microcontroller of the at least one other dissociating module for receiving information therefrom; and switches, operatively connected to the microcontroller. The microcontroller, based on at least one of the measurements of the object received and the information received from the at least one other dissociating module, controls opening and closing of the switches for controlling electrical current in the dissociating module.Type: ApplicationFiled: August 3, 2016Publication date: August 16, 2018Inventor: Marc VIDAL
-
Patent number: 7601533Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.Type: GrantFiled: February 13, 2006Date of Patent: October 13, 2009Assignees: The General Hospital Corporation, The John Hopkins UniversityInventors: Marc Vidal, Jef Boeke, Ed Harlow
-
Publication number: 20060286600Abstract: The invention relates to a new high throughput yeast one-hybrid screening system.Type: ApplicationFiled: June 30, 2004Publication date: December 21, 2006Inventors: Albertha Walhout, Marc Vidal, Bart Deplancke
-
Publication number: 20060223089Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.Type: ApplicationFiled: February 13, 2006Publication date: October 5, 2006Applicants: The Johns Hopkins University, The General Hospital CorporationInventors: Marc Vidal, Jef Boeke, Ed Harlow
-
Patent number: 7033768Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.Type: GrantFiled: December 21, 2001Date of Patent: April 25, 2006Assignees: The General Hospital Corporation, The John Hopkins UniversityInventors: Marc Vidal, Jef D. Boeke, Ed Harlow
-
Publication number: 20050053913Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.Type: ApplicationFiled: August 18, 2004Publication date: March 10, 2005Inventors: Marc Vidal, Jef Boeke, Ed Harlow
-
Publication number: 20030124538Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.Type: ApplicationFiled: December 21, 2001Publication date: July 3, 2003Applicant: The John Hopkins University, a Maryland corporationInventors: Marc Vidal, Jef Boeke, Ed Harlow
-
Publication number: 20030068612Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.Type: ApplicationFiled: June 26, 2002Publication date: April 10, 2003Applicant: The General Hospital Corporation, a Massachusetts corporationInventors: Marc Vidal, Jef D. Boeke, Ed Harlow
-
Publication number: 20020197627Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.Type: ApplicationFiled: March 27, 2002Publication date: December 26, 2002Applicant: The General Hospital Corporation, a Massachusetts corporationInventors: Marc Vidal, Jef D. Boeke, Ed Harlow
-
Patent number: 5965368Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.Type: GrantFiled: October 24, 1997Date of Patent: October 12, 1999Assignees: The General Hospital Corporation, The Johns Hopkins UniversityInventors: Marc Vidal, Jef D. Boeke, Ed Harlow
-
Patent number: 5955280Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.Type: GrantFiled: September 4, 1997Date of Patent: September 21, 1999Assignees: The General Hospital Corporation, The Johns Hopkins UniversityInventors: Marc Vidal, Jef D. Boeke, Ed Harlow